Delfini Lisa

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$44,956.36

Insider Activity of Delfini Lisa

According to the SEC Form 4 filings, Delfini Lisa, being in a position of

  1. Chief Financial Officer at Trevi Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 4350 shares for $11,485,
    over all time since 2023-02-13, has bought 0 shares, and sold 18593 shares for $44,956.

The largest sale of all time was on 2023-02-13 and amounted to 8474 shares of Trevi Therapeutics, Inc. for $20,761.

Biography of Delfini Lisa

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $11,4851100

Comparison of Insiders on Amount of Buys and Sells

2024-05-22SaleTrevi Therapeutics, Inc.
TRVI
Chief Financial Officer
4,350
0.0062%
$2.64$11,485+16.23%
2023-10-11SaleTrevi Therapeutics, Inc.
TRVI
Chief Financial Officer
785
0.0012%
$2.02$1,586+32.11%
2023-09-11SaleTrevi Therapeutics, Inc.
TRVI
Chief Financial Officer
711
0.0011%
$2.20$1,564+15.27%
2023-08-11SaleTrevi Therapeutics, Inc.
TRVI
Chief Financial Officer
682
0.0011%
$2.36$1,610-1.05%
2023-07-11SaleTrevi Therapeutics, Inc.
TRVI
Chief Financial Officer
687
0.0007%
$2.34$1,608+0.55%
2023-06-12SaleTrevi Therapeutics, Inc.
TRVI
Chief Financial Officer
610
0.0006%
$2.64$1,610-11.72%
2023-05-11SaleTrevi Therapeutics, Inc.
TRVI
Chief Financial Officer
562
0.0008%
$2.89$1,624-25.33%
2023-04-11SaleTrevi Therapeutics, Inc.
TRVI
Chief Financial Officer
840
0.0013%
$1.84$1,545+21.04%
2023-03-13SaleTrevi Therapeutics, Inc.
TRVI
Chief Financial Officer
892
0.0013%
$1.75$1,564+14.17%
2023-02-13SaleTrevi Therapeutics, Inc.
TRVI
Chief Financial Officer
8,474
0.0131%
$2.45$20,761-13.47%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.